معرفی
Sudha Sundar is a Professor of Gynaecological Cancer in the Department of Cancer and Genomic Sciences at the University of Birmingham, where she serves as a clinical academic and gynaecological cancer surgeon. She is actively involved in national and international leadership, currently serving as the National Ovarian Cancer Audit Surgical Lead (2023–present) and a member of the International Advisory Board of Lancet Oncology (2025–). Previously, she was President of the British Gynaecological Cancer Society (2019–2022), the first woman gynaecological oncologist to hold this role. She also serves as India Lead for the College of Medicine and Health (2017–present) and Academic Lead for the Cancer Pillar at Birmingham Health Partners (2018–present).
Research Interests: Her research program focuses on three core areas: improving cancer diagnostics, optimizing cancer surgery, and addressing inequalities in cancer outcomes. She leads clinical and translational research initiatives such as the ROCkeTS trial (diagnostic accuracy in ovarian cancer), the Global Equality in Ovarian Cancer Care Project (GEOCC), and studies on mucinous ovarian cancer (STEMOVA). Her work integrates clinical trials with genomic analysis and real-world data to drive policy change and improve patient outcomes.
Publications and Research Trends: Her recent publications reflect a strong emphasis on ovarian cancer diagnostics, surgical outcomes, health disparities, and guideline development. She frequently publishes in high-impact journals like Nature Genetics, Lancet Oncology, Gynecologic Oncology, and BJOG. Her work often involves large-scale data analysis, systematic reviews, and clinical guidelines, demonstrating a translational and policy-oriented research approach.
Scientific Leadership and Recognition:
- President, British Gynaecological Cancer Society (2019–2022)
- National Ovarian Cancer Audit Surgical Lead (2023–present)
- Co-Chair, International Gynaecological Cancer Society Conference Scientific Program Committee (2024)
- Member, International Advisory Board, Lancet Oncology (2025–)
- India Lead, College of Medicine and Health, University of Birmingham (2017–present)
- Academic Lead, Cancer Pillar, Birmingham Health Partners (2018–present)
- Lead, Ethnic Diversity in Cancer Genomics Substream, Institute of Global Innovation
Teaching and Mentoring: Professor Sundar provides bedside and small group teaching for Year 4 and Year 5 medical students and serves as a personal academic tutor for Year 1 and Year 2 students. She welcomes MD and PhD trainees interested in gynaecological oncology research.
Labs and Research Teams: She leads a multidisciplinary research team focused on gynaecological cancers, collaborating with institutions such as Imperial University and the Royal College of Obstetricians and Gynaecologists. Her work is supported by national audits, clinical trials (e.g., ROCkeTS), and international consortia like the International Gynaecological Cancer Society. She is deeply involved in using routinely collected health data to drive quality improvement and equity in cancer care.
